Related Experiment Videos
Biloma following transcatheter oily chemoembolization
Y Inoue1, H Nakamura, S Takashima
1Department of Radiology, Minoh City Hospital, Japan.
Radiation Medicine
|March 1, 1991
Summary
A bile cyst, or biloma, can form after transcatheter oily chemoembolization (TOCE) for liver cancer. Conservative management allowed for successful repeat TOCE, suggesting the procedure is still valuable despite this risk.
Area of Science:
- Hepatobiliary medicine
- Interventional oncology
- Hepatocellular carcinoma treatment
Background:
- Transcatheter oily chemoembolization (TOCE) is a standard treatment for hepatocellular carcinoma.
- Lipiodol, an iodized oil, is commonly used as a contrast agent and chemocarrier in TOCE.
- Biloma formation is a potential complication following hepatic interventions.
Observation:
- A patient developed hepatic biloma (bile cyst) subsequent to TOCE using Lipiodol for hepatocellular carcinoma.
- The biloma was managed conservatively.
- The patient subsequently underwent another TOCE procedure without complications.
Findings:
- Excessive doses of Lipiodol, chemotherapy agents, or Gelfoam may contribute to biloma development.
- Conservative management can be effective for post-TOCE bilomas.
- The occurrence of a biloma does not preclude future TOCE treatments.
Implications:
- Hepatocellular carcinoma patients can still benefit from TOCE even with the risk of biloma.
- Careful dosing of Lipiodol and embolic agents is crucial to minimize biloma risk.
- Conservative treatment strategies for biloma are viable, allowing continuation of oncological therapy.